Cabergoline
NDC 23155-823, Cabergoline, tablet, from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc..
- Product NDC
- 23155-823
- Status
- Listed
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076310
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/23155-823 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CABERGOLINE.5 mg/1
Pharmacologic classes
Ergolines [CS]; Ergot Derivative [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 23155-823-73 | 23155082373 | 8 TABLET in 1 BOTTLE (23155-823-73) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bc44d11b-b3f0-4e3d-9da3-4f8852d11734NADAC price for package 23155082373
GET /v1/drugs/nadac/23155082373
Use it
Look up 23155-823 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/23155-823 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 23155-823. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.